S. Pouwels (Groningen, Netherlands), A. Szczepankiewicz (Poznan, Poland), J. Jubrail (Edinburgh, United Kingdom)
Upregulation of Suppressors of Cytokine Signalling (SOCS)3 in COPD alveolar macrophages.
E. Bazzan (Padova (PD), Italy), M. Tinè (Padova (PD), Italy), G. Turato (Padova (PD), Italy), U. Semenzato (Padova (PD), Italy), M. Romagnoli (Treviso (TV), Italy), M. Cosio (Montreal, Canada), M. Saetta (Padova (PD), Italy)
|   |
The CDK4/6 inhibitor, palbociclib intensifies pulmonary inflammation in bleomycin-induced lung fibrosis
A. Birnhuber (Graz, Austria), B. Egemnazarov (Graz, Austria), V. Biasin (Graz, Austria), E. Rad (Graz, Austria), H. Olschewski (Graz, Austria), G. Kwapiszewska (Graz, Austria), L. Marsh (Graz, Austria)
| |
Alveolar presence of red blood cells correlates with alveolar macrophage iron levels in COPD
J. Baker (MANCHESTER, United Kingdom), M. Hammond (MANCHESTER, United Kingdom), J. Dungwa (MANCHESTER, United Kingdom), A. Higham (MANCHESTER, United Kingdom), S. Lea (MANCHESTER, United Kingdom), D. Singh (MANCHESTER, United Kingdom)
| |
The content of IgE and circulating immune complexes (CIC) in pregnant women with exacerbation of chronic simple bronchitis due to cytomegalovirus infection
V. Kolosov (Blagoveshchensk (Amur Oblast), Russian Federation), I. Gorikov (Blagoveshchensk (Amur Oblast), Russian Federation), I. Andrievskaya (Blagoveshchensk (Amur Oblast), Russian Federation), L. Nakhamchen (Blagoveshchensk (Amur Oblast), Russian Federation), N. Ishutina (Blagoveshchensk (Amur Oblast), Russian Federation)
| |
The relationship between Notch expression and T cell differentiation in COPD
C. Lin (Changhua City, Taiwan), Y. Li (Changhua City, Taiwan), H. Chang (Changhua City, Taiwan), S. Lin (Changhua City, Taiwan)
| |
Physiological role of olfactory receptors in alveolar macrophages
D. Weidinger (Bochum, Germany), D. Alisch (Bochum, Germany), K. Jamal Jameel (Bochum, Germany), M. Ruhe (Bochum, Germany), F. Yusuf (Bochum, Germany), S. Rohde (Bochum, Germany), J. Schalk (Bochum, Germany), P. Kaufmann (Bochum, Germany), J. Kronsbein (Bochum, Germany), M. Peters (Bochum, Germany), N. Giannakis (Bochum, Germany), H. Hatt (Bochum, Germany), J. Knobloch (Bochum, Germany)
| |
In vitro responses of peripheral blood mononuclear cells in severe asthma patient treated with Mepolizumab
F. Alhadian (Leicester, United Kingdom), J. Hakeem (Leicester, United Kingdom), A. Wright (Leicester, United Kingdom), S. Siddiqui (Leicester, United Kingdom), Y. Amrani (Leicester, United Kingdom)
| |
Levels of proteinase 3 and neutrophil elastase in plasma, BAL and biopsies in COPD
B. Jouleh (Bergen, Norway), I. Haaland (Bergen, Norway), F. Khorsand (Bergen, Norway), R. Sandvik (Bergen, Norway), T. Kalananthan (Bergen, Norway), R. Nielsen (Bergen, Norway), T. Jouleh (Bergen, Norway), H. Wiker (Bergen, Norway), P. Bakke (Bergen, Norway), N. Reuter (Bergen, Norway), T. Eagan (Bergen, Norway)
| |
Protease activated receptor 2 (PAR2) antagonism reduces pro-inflammatory cytokine production in bronchial epithelial cells
M. Bailo (Paisley, United Kingdom), L. Dunning (Paisley, United Kingdom), J. Brzeszczynska (Paisley, United Kingdom), K. Mcintosh (Glasgow, United Kingdom), R. Plevin (Glasgow, United Kingdom), S. Martin (Belfast, United Kingdom), G. P. Sergeant (Dundalk, Ireland), C. S. Goodyear (Glasgow, United Kingdom), G. S. Litherland (Paisley, United Kingdom), J. C. Lockhart (Paisley, United Kingdom), A. Crilly (Paisley, United Kingdom)
| |
FK506-binding protein 11, a novel plasma cell specific antibody folding catalyst, is increased in idiopathic pulmonary fibrosis
S. Preisendörfer (Munich, Germany), Y. Ishikawa (San Francisco, United States of America), L. Knüppel (Munich, Germany), I. Fernandez (Munich, Germany), L. Binzenhöfer (Munich, Germany), B. Juan-Guardela (Yale, United States of America), E. Hennen (Munich, Germany), C. Ruppert (Gießen, Germany), A. Guenther (Gießen, Germany), N. Kneidinger (Munich, Germany), M. Frankenberger (Munich, Germany), R. Hatz (Munich, Germany), J. Behr (Munich, Germany), A. Schepers (Munich, Germany), A. Hilgendorff (Munich, Germany), N. Kaminski (Yale, United States of America), H. Bächinger (Portland, United States of America), O. Eickelberg (Denver, United States of America), C. Staab-Weijnitz (Munich, Germany)
| |
Immunological profiling of chronic obstructive airways disease and idiopathic pulmonary fibrosis
J. Sellares Torres (Barcelona, Spain), N. Mendoza (Barcelona, Spain), S. Casas-Recasens (Barcelona, Spain), F. Hernández (Barcelona, Spain), N. Albacar (Barcelona, Spain), N. Guillaume (Barcelona, Spain), A. Agusti (Barcelona, Spain), R. Faner (Barcelona, Spain)
| |
Erythromycin Reverses Nets-induced Corticosteroid Insensitivity By Inhibition Of The Pi3kd/akt Pathway
Z. He (Nan Ning, China)
| |
THE PROGRESSION OF IMMUNE DISORDERS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE IS ASSOCIATED WITH CHANGES IN LEUKOCYTE MEMBRANE FATTY ACID COMPOSITION
Y. Denisenko (Vladivostok, Russian Federation), T. Novgorodtseva (Vladivostok, Russian Federation), M. Antonyuk (Vladivostok, Russian Federation), T. Gvozdenko (Vladivostok, Russian Federation)
| |
Multiplex immunohistochemistry to investigate inflammatory cell spatial organisation and interactions in severe asthma
L. Chachi (Leicester (Leicestershire), United Kingdom), J. Sousa (Leicester (Leicestershire), United Kingdom), C. Brightling (Leicester (Leicestershire), United Kingdom), Y. Amrani (Leicester (Leicestershire), United Kingdom)
| |
Determination of levels of markers of systemic inflammation in patients with chronic bronchitis in combination with concomitant gastroesophageal reflux disease
U. Shevchuk-Budz (Ivano-Frankivsk, Ukraine), M. Ostrovskyy (Ivano-Frankivsk, Ukraine), O. Varunkiv (Ivano-Frankivsk, Ukraine), I. Savelikhina (Ivano-Frankivsk, Ukraine), I. Makoyda (Ivano-Frankivsk, Ukraine), K. Ostrovska (Ivano-Frankivsk, Ukraine)
| |
Cross-talk between coagulation and inflammation in COPD. The role of Factor XIII.
E. Bazzan (Padova (PD), Italy), C. Radu (Padova (PD), Italy), M. Tinè (Padova (PD), Italy), U. Semenzato (Padova (PD), Italy), S. Baraldo (Padova (PD), Italy), G. Turato (Padova (PD), Italy), P. Simioni (Padova (PD), Italy), M. Cosio (Montreal, Canada), M. Saetta (Padova (PD), Italy)
| |
Evaluation of mRNA expression profiling of NF-?B mediated signaling in COPD patients.
R. Yadav (Lucknow, India), S. Kant (Lucknow, India), P. Tripathi (Lucknow, India), A. Pandey (Lucknow, India)
| |
Mechanisms of extracellular Hsp70 induced inflammatory effects in 16HBE cells
A. Hulina Tomaškovic (Zagreb, Croatia), A. Somborac-Bacura (Zagreb, Croatia), I. Hlapcic (Zagreb, Croatia), M. Grdic Rajkovic (Zagreb, Croatia), L. Rumora (Zagreb, Croatia)
| |
Estimation of DNA repair synthesis in peripheral blood lymphocytes from asthmatic patients treated with oral corticosteroids
A. Lintsov (St. Petersburg, Russian Federation), A. Soliev (St. Petersburg, Russian Federation), P. Slizhov (St. Petersburg, Russian Federation), . Shevelev (St. Petersburg, Russian Federation), I. Spivak (St. Petersburg, Russian Federation), V. Mikhelson (St. Petersburg, Russian Federation)
| |
The importance of innate and adaptive immunity in the formation of various variants of the course of seasonal allergic rhinitis
L. Sizyakina (Rostov-on-DonRostov-on-Don, Russian Federation), I. Andreeva (Rostov-on-DonRostov-on-Don, Russian Federation), N. Semenova (Rostov-on-DonRostov-on-Don, Russian Federation)
| |